•Polio and prevention
      •The virus
           •Vaccine-derived polioviruses
      •The vaccines
           •Oral polio vaccine (OPV)
           •Monovalent OPV
           •Bivalent OPV
           •Inactivated polio vaccine (IPV)
      •History of polio
 •Infected countries
      •Afghanistan
           •Afghanistan strategy
      •Nigeria
           •Nigeria strategy
      •Pakistan
           •Pakistan strategy
           •Angola strategy
           •Chad strategy
           •Democratic Republic of the Congo strategy
           •Sudan strategy
      •Importation countries
           •Central African Republic
           •Côte d'Ivoire
           •Kenya
           •Liberia
           •Mali
           •Niger
           •Somalia
           •Uganda
 •Data and monitoring
      •Polio this week
           •Polio cases worldwide
           •Polio-infected districts
           •Wild poliovirus list
           •Circulating vaccine-derived poliovirus
      •Surveillance
           •Global Polio Laboratory Network
           •Global indicators
           •Endemic region indicators
      •Social data
      •Polio campaign monitoring
           •Angola
           •Benin
           •Burkina Faso
           •Cameroon
           •Cape Verde
           •Central African Republic
           •Chad
           •Congo
           •Côte d'Ivoire
           •Democratic Republic of the Congo
           •Ethiopia
           •Gabon
           •Gambia
           •Ghana
           •Guinea
           •Guinea Bissau
           •Kenya
           •Liberia
           •Mali
           •Mauritania
           •Nepal
           •Niger
           •Rwanda
           •Senegal
           •Sierra Leone
           •Tajikistan
           •Tanzania
           •Togo
           •Uganda
           •Uzbekistan
      •Polio eradication targets
           •Supporting data
           •Risk assessments
           •Communications data
           •IMB reports
 •Post-eradication
      •Preparing for post eradication
      •Certification
      •OPV cessation
           •Risks
           •Prerequisites
           •Timeline
           •Frequently asked questions
 •Research
      •OPV efficacy
      •OPV delivery
      •Affordable IPV
      •Vaccine-derived polioviruses
      •Frequently asked questions
      •Polio Pipeline
           •No.9
           •No.8 Summer 2011
           •No.7 Winter 2011
                •Role of research in new Strategic Plan
                •New Independent Monitoring Board to assess progres
                •Key expert groups convene in India to evaluate new
                •The Polio Research Committee’s call for Proposals
                •Available and upcoming publications
                •Research evaluates progress
                •The role of research to eradicate polio in Nigeria
                •Mobile phones help assess quality of polio campaig
                •Research helps optimise outbreak response
           •No.6 Summer 2010
                •Research underpins roadmap to a polio-free world
                •Programmatic benefits of bivalent OPV
                •Programme evaluation
                •The importance of optimizing outbreak response
                •Pre-empting poliovirus
                •Outcomes of the Polio Research Committee
                •Call for recruitment
           •No.5 Winter 2010
                •Polio Research
                •Conclusions and recommendations
                •Research area 1
                •Research area 2
                •Delivering monovalent OPV
                •Independent evaluation calls for more research to
                •Global status of licensure
                •The use of LQAS
                •Where are the immunity gaps?
           •No.4 Summer 2009
                •Letter from the Chair of the Advisory Committee
                •Polio Research Committee reviews
                •India vaccine trials
                •Unmet research needs
                •CDC: leading research
                •Global post-eradication IPV
                •Polio Research Committee: one year on
                •Courtyard women strategy
           •No.3 Winter 2009
                •Polio research
                •Polio Research Committee outcomes
                •Unmet research needs
                •Update on improving IPV
                •The Poliovirus Antivirals Initiative
           •No 2, Autumn 2008
                •Polio eradication
                •Introduction of Real Time RT-PCR
                •KAP studies
                •The role of mathematical modelling
                •Vaccine development
                •Higher-potency mOPV1 in India
                •Role of new and existing vaccines
                •Seroprevalence surveys
           •No.1 Summer 2008
                •Welcome!
                •Polio Research Committee meeting
                •Eliminating needles
                •Improving IPV
                •Bivalent OPV
      •Polio Research Committee
      •Grants and collaboration
      •Antivirals
 •Financing
           •Oral polio vaccine supply
           •Supplementary immunization activities
           •Surveillance
           •Technical assistance
           •Social Mobilization and Communications
      •Donor contributions
      •Donate
 •Media room
      •News stories
           •News stories 2013
           •News stories 2012
           •News stories 2011
           •News stories 2010
           •News stories 2009
           •News stories 2008
      •Newsletter - Polio News
           •2011
                     •January
                     •February
                     •March
                     •April
                     •May
                     •June
                     •July
           •2010
                •December
                •October / November
                •September
                •July / August
                •June
                •May
                •April
                •March
                •February / March
                •January
           •2009
                •December
                •November
                •October
                •September
                •August
                •July
                •June
                •May
                •April
                •March
                •February
                •January
           •2008
                •December
                •November
                •October
                •September
                •August
                •July
                •June
                •May
                •March
                •February
                •January
           •2007
                •December
                •November
                •September/October
                •August
                •July
                •June
                •May
                •April
                •March
                •January
           •2006
                •December
                •September
                •August
                •July
                •June
                •May
                •April
                •March
                •February
                •January
           •2005
                •December
                •November
                •October
                •September
                •August
                •July
                •June
                •May
                •April
                •March
                •February
                •January
           •2011
           •2010
           •2009
           •2008
      •Fact sheets
      •Photos
           •Photo collections
           •Photo essays
      •Videos
      •Events
      •Subscribe
      •History
      •Strategy
           •Routine immunization
           •Supplementary immunization
           •Surveillance
           •Targeted mop-up campagins
      •Partners
           •Spearheading partners
      •Progress
      •Governance
           •Independent Monitoring Board
                •IMB Members
                •Reports
                •Meetings
                     •IMB Meeting - 5
                •Graphics
                •Press
                •Contact
      •Annual reports
      •Vacancies
      •Contact
      •Advisory and certification
           •Independent Monitoring Board
           •Strategic Advisory Group of Experts (SAGE)
           •Technical Advisory Groups
           •Polio Research Committee
           •Global Certification Commissions
           •Regional Certification Commissions
           •Advisory Committee on Poliomyelitis Eradication
      •Strategy and work
           •Strategic plan
           •Annual reports
           •Financial resource requirements
           •Emergency Action Plan
      •Reports to WHO governing bodies
      •GPLN publications
      •Resources for polio eradicators
           •Outbreak response guidelines
      •Declarations and resolutions
      •WHO Weekly Epidemiological Record
      •Evaluations
      •Post-eradication policy documents